Correlation Between 17298CHT8 and MEI Pharma
Specify exactly 2 symbols:
By analyzing existing cross correlation between US17298CHT80 and MEI Pharma, you can compare the effects of market volatilities on 17298CHT8 and MEI Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 17298CHT8 with a short position of MEI Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of 17298CHT8 and MEI Pharma.
Diversification Opportunities for 17298CHT8 and MEI Pharma
-0.47 | Correlation Coefficient |
Very good diversification
The 3 months correlation between 17298CHT8 and MEI is -0.47. Overlapping area represents the amount of risk that can be diversified away by holding US17298CHT80 and MEI Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MEI Pharma and 17298CHT8 is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on US17298CHT80 are associated (or correlated) with MEI Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MEI Pharma has no effect on the direction of 17298CHT8 i.e., 17298CHT8 and MEI Pharma go up and down completely randomly.
Pair Corralation between 17298CHT8 and MEI Pharma
Assuming the 90 days trading horizon US17298CHT80 is expected to generate 0.75 times more return on investment than MEI Pharma. However, US17298CHT80 is 1.33 times less risky than MEI Pharma. It trades about -0.01 of its potential returns per unit of risk. MEI Pharma is currently generating about -0.03 per unit of risk. If you would invest 8,388 in US17298CHT80 on October 22, 2024 and sell it today you would lose (128.00) from holding US17298CHT80 or give up 1.53% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 27.2% |
Values | Daily Returns |
US17298CHT80 vs. MEI Pharma
Performance |
Timeline |
US17298CHT80 |
MEI Pharma |
17298CHT8 and MEI Pharma Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with 17298CHT8 and MEI Pharma
The main advantage of trading using opposite 17298CHT8 and MEI Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 17298CHT8 position performs unexpectedly, MEI Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MEI Pharma will offset losses from the drop in MEI Pharma's long position.17298CHT8 vs. Ryanair Holdings PLC | 17298CHT8 vs. Nasdaq Inc | 17298CHT8 vs. Latamgrowth SPAC Unit | 17298CHT8 vs. Small Cap Premium |
MEI Pharma vs. Kezar Life Sciences | MEI Pharma vs. Vincerx Pharma | MEI Pharma vs. Avenue Therapeutics | MEI Pharma vs. Assembly Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Other Complementary Tools
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |